Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 4124348)

Published in World J Gastroenterol on March 21, 2006

Authors

Károly Palatka1, Zoltán Serfozo, Zoltán Veréb, Róbert Bátori, Beáta Lontay, Zoltán Hargitay, Zoltán Nemes, Miklós Udvardy, Ferenc Erdodi, István Altorjay

Author Affiliations

1: 2nd Department of Internal Medicine, Medical and Health Science Center, University of Debrecen, Nagyerdei körút 98, Debrecen H-4001, Hungary. palatka@jaguar.unideb.hu

Articles cited by this

Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet (1989) 5.70

Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest (1997) 4.92

Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A (2001) 3.88

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest (1997) 3.39

Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med (1997) 2.76

Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut (1996) 2.28

Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation (1998) 2.25

Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res (1993) 1.98

The effect of nitric oxide on cell respiration: A key to understanding its role in cell survival or death. Proc Natl Acad Sci U S A (2000) 1.96

Cellular adhesion molecules and atherogenesis. Am J Med (1999) 1.88

Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett (1992) 1.79

Nitric oxide-an endothelial cell survival factor. Cell Death Differ (1999) 1.70

Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med (2001) 1.69

NO and angiogenesis. Atheroscler Suppl (2003) 1.64

Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol (1996) 1.63

Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int J Obes Relat Metab Disord (2002) 1.54

Nitric oxide partitioning into mitochondrial membranes and the control of respiration at cytochrome c oxidase. Proc Natl Acad Sci U S A (2001) 1.53

VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun (1998) 1.51

Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J Biol Chem (2000) 1.49

Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease. J Clin Pathol (2003) 1.47

Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest (1994) 1.46

eNOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization. Circ Res (2001) 1.45

Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation. Gastroenterology (2003) 1.44

Role of nitric oxide in the modulation of angiogenesis. Curr Pharm Des (2003) 1.35

Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res (1993) 1.35

Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J Biol Chem (2000) 1.25

Endothelial nitric oxide synthase and endothelial dysfunction. Curr Hypertens Rep (2003) 1.22

Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail Rev (2002) 1.16

Differential response to myocardial reperfusion injury in eNOS-deficient mice. Am J Physiol Heart Circ Physiol (2002) 1.13

Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. Circulation (1999) 1.10

[Nitric oxide and inflammatory bowel disease]. Rev Esp Enferm Dig (1998) 1.08

Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem Biophys Res Commun (1993) 1.06

iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. Am J Physiol (1998) 1.05

Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells. J Mol Cell Cardiol (2004) 1.05

Nitric oxide and inflammatory bowel diseases. Eur J Clin Invest (1998) 1.04

Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP. Atherosclerosis (1999) 1.04

Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease. Scand J Gastroenterol (2005) 0.99

Effects of interferon-gamma on nitric oxide synthase activity and endothelin-1 production by vascular endothelial cells. J Clin Invest (1992) 0.97

Vascular endothelial growth factor in inflammatory bowel disease. Int J Colorectal Dis (2003) 0.96

Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activity. Eur J Pharmacol (2005) 0.95

Antioxidants and the bioactivity of endothelium-derived nitric oxide. Cardiovasc Res (2000) 0.94

Increased disease activity in eNOS-deficient mice in experimental colitis. Free Radic Biol Med (2003) 0.93

Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion. Free Radic Biol Med (2000) 0.92

Regulation of ICAM-1/CD54 expression on human endothelial cells by hydrogen peroxide involves inducible NO synthase. J Leukoc Biol (2000) 0.91

Altered expression of angiogenic factors in the VEGF-Ets-1 cascades in inflammatory bowel disease. J Gastroenterol (2004) 0.91

Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock. Circulation (1999) 0.90

Relaxin potentiates the expression of inducible nitric oxide synthase by endothelial cells from human umbilical vein in in vitro culture. Mol Hum Reprod (2004) 0.89

Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas: correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn's disease. Amino Acids (2000) 0.88

Expression of inducible nitric oxide synthase in human umbilical vein endothelial cells during primary culture. Nitric Oxide (2002) 0.86

Antioxidants inhibit angiogenesis in vivo through down-regulation of nitric oxide synthase expression and activity. Free Radic Res (2004) 0.84

EGF induces nuclear translocation of STAT2 without tyrosine phosphorylation in intestinal epithelial cells. Am J Physiol (1999) 0.83

Activation of microvascular endothelial cells in active ulcerative colitis and detection of inducible nitric oxide synthase. J Clin Gastroenterol (1998) 0.82

Changes in distribution of three isoforms of nitric oxide synthase in ulcerative colitis. Scand J Gastroenterol (2001) 0.79

The effects of nitric oxide on prostanoid production and release by human umbilical vein endothelial cells. Life Sci (2003) 0.77

Articles by these authors

Myosin phosphatase: structure, regulation and function. Mol Cell Biochem (2004) 3.02

Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of Serine 695 in response to cyclic nucleotides. J Biol Chem (2004) 1.81

Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells. FEBS Lett (2005) 1.59

Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase. Biochem J (2002) 1.59

Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease. Gastroenterology (2010) 1.50

Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration. Autophagy (2013) 1.34

Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V. J Biol Chem (2005) 1.34

Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study. Inflamm Bowel Dis (2010) 1.15

Integrin-linked kinase phosphorylates the myosin phosphatase target subunit at the inhibitory site in platelet cytoskeleton. Biochem J (2002) 1.15

Peroxidasin is secreted and incorporated into the extracellular matrix of myofibroblasts and fibrotic kidney. Am J Pathol (2009) 1.07

Okadaic acid induces phosphorylation and translocation of myosin phosphatase target subunit 1 influencing myosin phosphorylation, stress fiber assembly and cell migration in HepG2 cells. Cell Signal (2005) 1.02

Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease. Scand J Gastroenterol (2005) 0.99

Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 0.92

Myosin phosphatase and myosin phosphorylation in differentiating C2C12 cells. J Muscle Res Cell Motil (2003) 0.92

Localization of myosin phosphatase target subunit and its mutants. J Muscle Res Cell Motil (2005) 0.90

Myosin phosphatase interacts with and dephosphorylates the retinoblastoma protein in THP-1 leukemic cells: its inhibition is involved in the attenuation of daunorubicin-induced cell death by calyculin-A. Cell Signal (2008) 0.89

In vivo target sites of nitric oxide in photosynthetic electron transport as studied by chlorophyll fluorescence in pea leaves. Plant Physiol (2008) 0.88

Pathology of chronic obstructive pulmonary disease. Pathol Oncol Res (2006) 0.87

Cylindrospermopsin induces alterations of root histology and microtubule organization in common reed (Phragmites australis) plantlets cultured in vitro. Toxicon (2009) 0.86

Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head. Blood Coagul Fibrinolysis (2003) 0.86

Autologous dendritic cell based adoptive immunotherapy of patients with colorectal cancer-A phase I-II study. Pathol Oncol Res (2013) 0.86

Localization of myosin phosphatase target subunit 1 in rat brain and in primary cultures of neuronal cells. J Comp Neurol (2004) 0.86

Cultivation and characterization of cornea limbal epithelial stem cells on lens capsule in animal material-free medium. PLoS One (2012) 0.85

The role of microglia/macrophage system in the tissue response to I-125 interstitial brachytherapy of cerebral gliomas. Neurol Res (2007) 0.84

Characterization of the effect of TIMAP phosphorylation on its interaction with protein phosphatase 1. Biochimie (2011) 0.84

Cyclic AMP response element-binding (CREB)-like proteins in a molluscan brain: cellular localization and learning-induced phosphorylation. Eur J Neurosci (2003) 0.84

Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease. Hum Mutat (2005) 0.84

Synthesis and evaluation of phosphorus containing, specific CDK9/CycT1 inhibitors. J Med Chem (2014) 0.83

TASK-3 immunoreactivity shows differential distribution in the human gastrointestinal tract. Virchows Arch (2005) 0.83

Microcystin-LR induces abnormal root development by altering microtubule organization in tissue-cultured common reed (Phragmites australis) plantlets. Aquat Toxicol (2009) 0.82

p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma. J Oral Pathol Med (2005) 0.82

Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational study. BMC Gastroenterol (2009) 0.82

Primary rhabdoid cancer of the ileum: a case report and review of the literature. Pathol Res Pract (2009) 0.82

Mesenchymal stem cell like (MSCl) cells generated from human embryonic stem cells support pluripotent cell growth. Biochem Biophys Res Commun (2011) 0.81

Laboratory evaluation of a flow cytometric BCR-ABL immunobead assay. Clin Chem Lab Med (2011) 0.80

Evidence for pentagalloyl glucose binding to human salivary alpha-amylase through aromatic amino acid residues. Biochim Biophys Acta (2008) 0.80

Thyroid hormones affect the level and activity of nitric oxide synthase in rat cerebral cortex during postnatal development. Neurochem Res (2007) 0.79

Comparison of upstream regulators in human ex vivo cultured cornea limbal epithelial stem cells and differentiated corneal epithelial cells. BMC Genomics (2013) 0.78

Tissue response to iodine-125 interstitial brachytherapy of cerebral gliomas. Prog Neurol Surg (2007) 0.78

[Association of Hodgkin lymphoma with Epstein-Barr virus in Hungary]. Orv Hetil (2005) 0.78

WT1 overexpression affecting clinical outcome in non-hodgkin lymphomas and adult acute lymphoblastic leukemia. Pathol Oncol Res (2013) 0.77

Pgp and FLT3: identification and modulation of two proteins that lead to chemotherapy resistance in acute myeloid leukemia. Curr Med Chem (2007) 0.77

[Relevance of serologic studies in inflammatory bowel diseases]. Orv Hetil (2007) 0.77

Microcystin-LR, a protein phosphatase inhibitor, induces alterations in mitotic chromatin and microtubule organization leading to the formation of micronuclei in Vicia faba. Ann Bot (2012) 0.77

Estrogen signalling in the pathogenesis of age-related macular degeneration. Curr Eye Res (2014) 0.77

Differential effects of phosphatase inhibitors on the calcium homeostasis and migration of HaCaT keratinocytes. PLoS One (2013) 0.77

Development of the nitric oxide/cGMP system in the embryonic and juvenile pond snail, Lymnaea stagnalis L. A comparative in situ hybridization, histochemical and immunohistochemical study. J Neurocytol (2002) 0.77

[Evaluation of survival in mixed connective tissue disease (MCTD)]. Orv Hetil (2002) 0.77

Enhanced regeneration of corneal tissue via a bioengineered collagen construct implanted by a nondisruptive surgical technique. Tissue Eng Part A (2015) 0.76

Chronic inhibition of nitric oxide synthase activity by NG-nitro-L-arginine induces nitric oxide synthase expression in the developing rat cerebellum. Neurochem Int (2012) 0.76

[Complementary therapies--based on the principles of evidence-based medicine. Position statement of the Medical Sciences Section of the Hungarian Academy of Sciences]. Orv Hetil (2011) 0.76

[Autologous bone marrow stem cell or peripheral blood endothelial progenitor cell therapy in patients with peripheral limb ischaemia]. Orv Hetil (2006) 0.76

Myofilament protein carbonylation contributes to the contractile dysfunction in the infarcted LV region of mouse hearts. Cardiovasc Res (2013) 0.76

[Paroxysmal nocturnal hemoglobinuria]. Orv Hetil (2002) 0.76

Granulocyte colony stimulating factor increases drug resistance of leukaemic blast cells to daunorubicin. Pathol Oncol Res (2008) 0.76

[Successful alemtuzumab treatment of a patient with atypical hairy cell leukaemia variant]. Orv Hetil (2007) 0.76

Detection of internal tandem duplications in the FLT3 gene by different electrophoretic methods. Clin Chem Lab Med (2011) 0.75

Catheter-directed thrombolysis in inflammatory bowel diseases: report of a case. World J Gastroenterol (2012) 0.75

[Autologous bone marrow-derived stem cell therapy in patients with severe peripheral arterial disorder]. Orv Hetil (2008) 0.75

Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment. Platelets (2012) 0.75

Management of peptic ulcer bleeding in different case volume workplaces: results of a nationwide inquiry in hungary. Gastroenterol Res Pract (2012) 0.75

[Immunohistochemical demonstration of mutant nucleophosmin in acute myeloid leukemia: biological and clinical features related to NPMc expression]. Orv Hetil (2009) 0.75

[Prevention and treatment of esophageal variceal bleeding]. Orv Hetil (2006) 0.75

[The pathophysiology, clinical signs and therapy of urate nephropathy]. Orv Hetil (2007) 0.75

[New perspectives in the evolution of prognosis and treatment of chronic lymphocytic leukaemia]. Orv Hetil (2004) 0.75

Correction: Myosin phosphatase and RhoA-activated kinase modulate neurotransmitter release by regulating SNAP-25 of SNARE complex. PLoS One (2017) 0.75

[In memoriam: Kálmán Rák (1929-2005) - Imre Hirschler (1906-1989)]. Orv Hetil (2007) 0.75

[Chronic neutrophilic leukemia: a long-term analysis of seven cases and review of the literature]. Orv Hetil (2006) 0.75

[High-dose chemotherapy followed by autologous CD34+ stem cell transplantation in the treatment of severe refractory multisystem autoimmune diseases of adults--first experiences in Hungary]. Orv Hetil (2008) 0.75

[Changes in hematologic and hemostatic parameters after transjugular intrahepatic portosystemic shunt (TIPS) implantation]. Orv Hetil (2003) 0.75

[Experience with fludarabine treatment and review of the literature]. Orv Hetil (2002) 0.75

[Gastroesophageal variceal haemorrhage--new advances in pathophysiology]. Orv Hetil (2006) 0.75

[Prognositc value of CD38 cell surface marker in chronic lymphocytic leukemia]. Orv Hetil (2003) 0.75

[Novel aspects in the pathogenesis of gastroesophageal reflux disease]. Orv Hetil (2009) 0.75

The place of gastro-jejuno-duodenal interposition following limited esophageal resection. Eur J Cardiothorac Surg (2005) 0.75

[Haptoglobin polymorphism in patients with inflammatory bowel diseases]. Orv Hetil (2006) 0.75

[Primary treatment of advanced Hodgkin's disease]. Orv Hetil (2005) 0.75

Chromosomal aberrations and CD38 expression in two siblings with B-cell chronic lymphocytic leukemia: a report of two siblings. Leuk Lymphoma (2005) 0.75

[Hungarian data on inflammatory bowel diseases: analytical data on ulcerative colistis]. Orv Hetil (2012) 0.75

[Bacterial infections in liver cirrhosis]. Orv Hetil (2007) 0.75

Gastroesophageal reflux disease: work-related disease? Dig Dis (2009) 0.75